Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Cheng

Showing results (1201-1210 of 1,244) with videos related to

Pageof 125
Sort By:
Plos Biology|June 14, 2019
Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapyYun-Chi Lu, Chih-Hung Chuang, Kuo-Hsiang Chuang, et al.
The Lancet. Digital Health|August 11, 2023
Accurate classification of pulmonary nodules by a combined model of clinical, imaging, and cell-free DNA methylation biomarkers: a model development and external validation studyJianxing He, Bo Wang, Jinsheng Tao, et al.
Analytical Chemistry|May 10, 2017
Enhancement Effect of a Variable Topology of a Membrane-Tethered Anti-Poly(ethylene glycol) Antibody on the Sensitivity for Quantifying PEG and PEGylated MoleculesWen-Wei Lin, Yi-An Cheng, Chien-Han Kao, et al.
Therapeutic Advances in Medical Oncology|January 6, 2021
PD-L1 expression with respect to driver mutations in non-small cell lung cancer in an Asian population: a large study of 1370 cases in ChinaCaichen Li, Jun Liu, Zhanhong Xie, et al.
Nature Communications|November 7, 2025
Critical length screening enables 19% efficiency in thick-film organic solar cellsYuan Meng, Bo Cheng, Dongcheng Jiang, et al.
Bioengineering & Translational Medicine|October 1, 2025
Spatial-hindrance-based pro-Adalimumab prevents anti-idiotypic antibody interference in pharmacokinetic and therapeutic efficacyBo-Cheng Huang, Yu-Tung Chen, Yun-Chi Lu, et al.
Heliyon|April 16, 2024
Correlation between NGS panel-based mutation results and clinical information in colorectal cancer patientsBo Cheng, Lin Xu, Yunzhi Zhang, et al.
International Journal of Biological Macromolecules|March 7, 2026
Engineering tumor-specific interferon-alpha-Nivolumab pro-immunocytokine for enhanced melanoma immunotherapyShi-Wei Chao, Bo-Cheng Huang, Shih-Ting Hong, et al.
Journal of Nanobiotechnology|February 1, 2022
A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodiesYuan-Chin Hsieh, Jun-Min Liao, Kuo-Hsiang Chuang, et al.
Scientific Reports|July 22, 2021
Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapyWen-Wei Lin, Yun-Chi Lu, Bo-Cheng Huang, et al.
Pageof 125

Showing results (1201-1210 of 1,244) with videos related to

Sort By:
Pageof 125
Plos Biology|June 14, 2019
Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapyYun-Chi Lu, Chih-Hung Chuang, Kuo-Hsiang Chuang, et al.
The Lancet. Digital Health|August 11, 2023
Accurate classification of pulmonary nodules by a combined model of clinical, imaging, and cell-free DNA methylation biomarkers: a model development and external validation studyJianxing He, Bo Wang, Jinsheng Tao, et al.
Analytical Chemistry|May 10, 2017
Enhancement Effect of a Variable Topology of a Membrane-Tethered Anti-Poly(ethylene glycol) Antibody on the Sensitivity for Quantifying PEG and PEGylated MoleculesWen-Wei Lin, Yi-An Cheng, Chien-Han Kao, et al.
Therapeutic Advances in Medical Oncology|January 6, 2021
PD-L1 expression with respect to driver mutations in non-small cell lung cancer in an Asian population: a large study of 1370 cases in ChinaCaichen Li, Jun Liu, Zhanhong Xie, et al.
Nature Communications|November 7, 2025
Critical length screening enables 19% efficiency in thick-film organic solar cellsYuan Meng, Bo Cheng, Dongcheng Jiang, et al.
Bioengineering & Translational Medicine|October 1, 2025
Spatial-hindrance-based pro-Adalimumab prevents anti-idiotypic antibody interference in pharmacokinetic and therapeutic efficacyBo-Cheng Huang, Yu-Tung Chen, Yun-Chi Lu, et al.
Heliyon|April 16, 2024
Correlation between NGS panel-based mutation results and clinical information in colorectal cancer patientsBo Cheng, Lin Xu, Yunzhi Zhang, et al.
International Journal of Biological Macromolecules|March 7, 2026
Engineering tumor-specific interferon-alpha-Nivolumab pro-immunocytokine for enhanced melanoma immunotherapyShi-Wei Chao, Bo-Cheng Huang, Shih-Ting Hong, et al.
Journal of Nanobiotechnology|February 1, 2022
A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodiesYuan-Chin Hsieh, Jun-Min Liao, Kuo-Hsiang Chuang, et al.
Scientific Reports|July 22, 2021
Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapyWen-Wei Lin, Yun-Chi Lu, Bo-Cheng Huang, et al.
Pageof 125